About this trial
Intra-hospital transport is a frequent procedure in the ICU, involving patients with the highest severity scores. Although some studies estimate the rate of adverse events to be around 33% during intra-hospital transport, including 4% of serious adverse events, the epidemiological data available is small, heterogeneous, and probably subject to methodological bias.
The aim of this study observational prospective observatoinal study is to determine:
* the different practices existing between ICUs ("practice survey") * the occurrence of adverse events during intra-hospital transport provided by intensive care units (epidemiological study)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged over 18 years old
Hospitalized in ICU
Requiring an intra-hospital transport (e.g imagery, operating room, etc) by the ICU team
With a departure from ICU and arrival to ICU
Disqualifiers
Person under guardianship
Protected Majors
Already included in the study
Transport for an ICU discharge in a medical or surgical ward
Trial population
All patients hospitalized in an ICU and requiring an intra-hospital transport with a departure from ICU and arrival to ICU will be eligible.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of adverse events during intra-hospital transport in critical ill patients managed by an ICU team
The number of adverse events during intra-hospital transport managed by an ICU team, as a proportion of the number of transports performed.
Secondary outcomes
Incidence of non-serious adverse events occurring during intra-hospital transport.
3\) Rate of types of (non-serious) adverse events occurring during intra-hospital transport including O Rate of Withdrawal or mobilization of equipment with low risk of serious complication (e.g. VVP withdrawal, urinary catheter, nasogastric tube, mobilization of endotracheal tube without extubation) O Rate of Non-severe hemodynamic failures (occurrence of arterial hypotension with MAP between 40 and 65 mmHg, or catecholamine increase \< 10% during transport) O Rate of Non-severe respiratory failure (desaturation with a SpO2 ≥ 80%) O Rate of Metabolic failure (e.g. hypoglycemia on return from transport) O Rate of Neurological complications (consciousness disorders occurring without sedation, agitation) O Rate of Material failures (O2 or ventilator failure, electrical syringe pump failure)
Incidence of serious adverse events occurring during intra-hospital transport.
4\) Rate of serious adverse events occurring during intra-hospital transport including O Death O Cardiorespiratory arrest O Accidental extubation and/or need for re-intubation, or removal of high-risk equipment (e.g. central venous catheter, arterial catheter, endotracheal tube) O Severe hemodynamic failure (arterial hypotension with MAP \< 40 mmHg, introduction or increase of catecholamines ≥ 10% during transport) O Severe respiratory failure (desaturation with SpO2 \< 80% or massive inhalation)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.